Bausch + Lomb Corporation
Bausch + Lomb Corporation (BLCO.TO) Revenue
Annual & quarterly revenue history · segment & region breakdown
BLCO.TO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBausch + Lomb Corporation trailing twelve-month (TTM) revenue is $5.20B, an increase of 6.47% year-over-year from $5.10B in FY2025.
Revenue trend
2025 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $5.10B | +$0.31B | +6.47% |
| 2024-12-31 | $4.79B | +$0.65B | +15.56% |
| 2023-12-31 | $4.15B | +$0.38B | +10.03% |
| 2022-12-31 | $3.77B | +$0.00B | +0.08% |
| 2021-12-31 | $3.77B | +$0.35B | +10.35% |
| 2020-12-31 | $3.41B | -$0.37B | -9.69% |
| 2019-12-31 | $3.78B | +$0.11B | +3.08% |
| 2018-12-31 | $3.67B | — | — |
Compare revenue vs peers
Medical - Instruments & SuppliesCompare BLCO.TO revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Bausch + Lomb Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Bausch + Lomb Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Bausch + Lomb Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BLCO.TO revenue · 4 questionsBLCO.TO's trailing twelve-month (TTM) revenue is $5.20B. That is an increase of 6.47% year-over-year from $5.10B in FY2025.
▸ Source: FMP · Bausch + Lomb Corporation SEC filings · GAAP · Bausch + Lomb Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026